In this article, we describe a model in which R&D organizations develop a sourcing strategy that is aligned with how they add value to their customers and shareholders.
Learn how we continuously improve pKa prediction accuracy for novel therapeutic modalities, such as PROTACs. Read More
In this article, we describe a model in which R&D organizations develop a sourcing strategy that is aligned with how they add value to their customers and shareholders.